Oasmia Pharmaceutical AB (OASM) At $1.12 Forms Bottom; Gold Standard Ventures (NYSEAMERICAN:GSV) Shorts Up By 14.79%

Oasmia Pharmaceutical AB (OASM) formed multiple bottom with $1.06 target or 5.00% below today’s $1.12 share price. Oasmia Pharmaceutical AB (OASM) has $75.72 million valuation. The stock increased 19.09% or $0.18 during the last trading session, reaching $1.12. About 45,301 shares traded or 715.06% up from the average. Oasmia Pharmaceutical AB (NASDAQ:publ) has 0.00% since January 15, 2017 and is . It has underperformed by 16.70% the S&P500.

Gold Standard Ventures Corporation (NYSEAMERICAN:GSV) had an increase of 14.79% in short interest. GSV’s SI was 8.22 million shares in January as released by FINRA. Its up 14.79% from 7.16 million shares previously. With 252,500 avg volume, 33 days are for Gold Standard Ventures Corporation (NYSEAMERICAN:GSV)’s short sellers to cover GSV’s short positions. The SI to Gold Standard Ventures Corporation’s float is 5.18%. The stock increased 1.94% or $0.03 during the last trading session, reaching $1.58. About 396,250 shares traded or 6.51% up from the average. Gold Standard Ventures Corp (NYSEAMERICAN:GSV) has 0.00% since January 15, 2017 and is . It has underperformed by 16.70% the S&P500.

Gold Standard Ventures Corp., an exploration stage company, engages in the acquisition and exploration of gold-bearing mineral resource properties in Nevada, the United States. The company has market cap of $361.79 million. The Company’s flagship property is the Railroad-Pinion project covering approximately 52,731 gross acres of land in Elko County, Nevada. It currently has negative earnings. As of March 30, 2017, the firm owns or has an option on the ownership of 29,103 gross acres of subsurface mineral rights in the form of patented or unpatented lode ; and a 23,628 gross acres of subsurface mineral rights secured or controlled by a contractual interest in private surface and mineral property.